Compare Tata India Pharma & Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.15
1.87
NAV
₹29.39
₹38.59
Fund Started
04 Dec 2015
25 Jun 2018
Fund Size
₹1229.42 Cr
₹6293.14 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 1% if redeemed within 15 days.
1 Year
1.54%
5.59%
3 Year
21.58%
26.04%
5 Year
12.98%
15.55%
Equity
99.69%
97.62%
Cash
0.31%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.34% |
Abbott India Ltd. | 5.89% |
Divi's Laboratories Ltd. | 5.83% |
Healthcare Global Enterprises Ltd. | 5.39% |
Max Healthcare Institute Ltd. | 5.14% |
Cipla Ltd. | 5.10% |
Apollo Hospitals Enterprise Ltd. | 4.25% |
Rainbow Children's Medicare Ltd. | 4.23% |
Mankind Pharma Ltd. | 3.57% |
Bayer CropScience Ltd. | 3.51% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
04 Dec 2015
25 Jun 2018
